Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06899516

Project MILANO: Connections Between Patients With Brain Tumors and Their Pets: an Analysis of Concerns and Needs

Context and problem

In France, 61% of households own a pet, highlighting the significant role pets play in the daily lives. Patients diagnosed with brain tumors face specific challenges that may affect their ability to care their pets, including:

* Progressive neurological deficits (cognitive and/or motor), limiting their autonomy, * A life-threatening prognosis.

In this context, the well-being of pets when their owner's health deteriorates becomes a critical concern. Indeed:

* Social isolation and the progressive loss of physical and cognitive abilities complicate pet care, particularly during prolonged hospitalizations or in the event of death, * The lack of appropriate facilities and care solutions causes stress for pets, who are often unprepared for such transitions, and adds to the emotional burden on patients.

Why focus on patients with brain tumors?

* These patients have specific needs due to the rapid progression of their condition, * A local study showed that 12% of patients with gliomas live alone, a significantly higher rate than in other cancer types. Patients who live alone are particularly exposed to issues related to their pet's future, * Given the high morbidity and mortality associated with brain tumors, proactive planning for pet care is particularly urgent.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU Saint Etienne

Saint-Etienne, 42000, France

Location status: Recruiting

Location contact

Carole Ramirez, Md

CONTACT

[email protected]

(0)477829326 ext. +33

Carole Ramirez, Md

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients diagnosed with a brain tumor.
  • Patients who own at least one pet.

Exclusion criteria

  • Patients who decline to participate in the study.
  • Patients unable to complete the questionnaire.

Treatment and study plan

The Lexington Attachment to Pets Scale (LAPS; Johnson, Garrity, & Stallones, 1992)

Other

The LAPS is a established tool for measuring the emotional bond between humans and their animal companions. Animal attachment is assessed according to three factors: the bond between owners and their dogs or cats, the closeness of the human-animal relationship, and the importance of the animal in the owner's life (Johnson et al., 1992). Higher scores indicate greater attachment.

Primary outcomes

  1. LAPS scale

    Time frame: Day 1

    The Lexington Pet Attachment Scale (LAPS) measures the percentage of patients who are concerned about their pets. Values range from zero to one hundred, with higher scores indicating greater concern for pets.

Secondary outcomes

  1. Questionnaire

    Time frame: Day 1

    A questionnaire that measures the percentage of patients who need more information and details of resources and support systems to help them with their pets.

Study contacts

Contact information is provided by the study sponsor or research team.

Carole Ramirez, Md

CONTACT

[email protected]

(0)477829326 ext. +33

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Saint Etienne

Other

Registry information

Acronym: MILANO

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Mar 28, 2025
Registry last updated
Apr 3, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.